China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017

— 4Q17 Total Sales Up 12.2% YoY and Non-GAAP Adjusted Net Income Down 6.8% YoY in RMB terms, or Total Sales Up 16.1% YoY to $90.1 Million and Net Income Down 226.8% YoY to a net loss of $24.6 Million in USD terms — — FY17 Total Sales Up 10.5% YoY and …
( read original story …)